A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Conditions:   Recurrent Langerhans Cell Histiocytosis;   Refractory Langerhans Cell Histiocytosis Interventions:   Procedure: Biospecimen Collection;   Procedure: Bone Marrow Aspiration;   Procedure: Bone Marrow Biopsy;   Procedure: Computed Tomography;   Procedure: Echocardiography;   Procedure: FDG-Positron Emission Tomography and Computed Tomography Scan;   Procedure: Lumbar Puncture;   Procedure: Multigated Acquisition Scan;   Drug: Tovorafenib Sponsor:   National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2023 Category: Research Source Type: clinical trials

NIH-Funded Study Finds Doxycycline Reduces Sexually Transmitted Infections by Two-Thirds
April 6, 2023 -- The oral antibiotic doxycycline prevented the acquisition of sexually transmitted infections (STIs) when tested among men who have sex with men (MSM) and transgender women who took the medication within 72 hours of having condomless... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 7, 2023 Category: Pharmaceuticals Source Type: clinical trials

Study on Data Acquisition and Image Characteristics of Brain Multifrequency EIT in Healthy People and Patients With Brain Diseases
Conditions:   Cerebral Hemorrhage;   Cerebral Ischemia;   Cerebral Edema;   Healthy Intervention:   Diagnostic Test: multifrequency EIT-based for detecting intracranial abnormalities Sponsor:   Jieshi Ma Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials